Drugs from bugs: NIH grant supports development of unique psoriasis treatment at Kansas State University

Posted on November 1, 2018

Philip Hardwidge, a microbiologist and biochemist at Kansas State University, has received a $218,593 grant from the National Institutes of Health for enhancing the development of drug treatments for psoriasis, a chronic inflammatory skin disease.

View article source to read more